Dr. Joanne van Ryn
Global Director, Dabigatran Scientific Support
Department CardioMetabolic Disease Research
Boehringer Ingelheim Pharma GmbH & Co KG
Scientific profile
- Antithrombotic and anticoagulant properties of heparin fractions and similar compounds
- Role of thrombin inhibition in disease processes
- Research and development of a specific reversal agent for dabigatran